ÀÌÀºÁÖ ¸íÀÇ

³­¼Ò¾Ï ¼ö¼ú ¸íÀÇ

ÀÌÀºÁÖ ¸íÀÇ

  • ¼Ò ¼Ó
    Áß¾Ó´ëÇб³º´¿ø »êºÎÀΰú
  • Àü¹®ºÐ¾ß
    ºÎÀξÏ(ÀڱðæºÎ¾Ï, ³­¼Ò¾Ï, Àڱ󻸷¾Ï), ÀڱñÙÁ¾, ³­¼ÒÁ¾¾ç, ´ÜÀϰø°ñ¹Ý°æ¼ö¼ú, ·Îº¿¼ö¼ú, Àڱðæ¼ö¼ú

ÀÌÀºÁÖ ±³¼ö´Â ¡®DKK3' À¯ÀüÀÚ°¡ ¾Ï¼¼Æ÷ ¾ïÁ¦ À¯ÀüÀÚ¶ó´Â »ç½ÇÀ» ÃÖÃÊ·Î ±Ô¸íÇϰí, ¾Ï¼¼Æ÷ ¾ïÁ¦ À¯ÀüÀÚ ¡®DKK3¡¯ À¯ÀüÀÚ¸¦ ÀÌ¿ëÇÑ ¾Ï Ä¡·áÁ¦ ¿¬±¸ °³¹ßÀ» Çϰí ÀÖ´Ù. DKK3 ¶ó´Â ´Ü¹éÁúÀÌ ´ëºÎºÐÀÇ ºÎÀÎ¾Ï ¼¼Æ÷¿¡¼­ ¹ßÇöÀÌ °¨¼ÒµÇ¾î ÀÖ°í ¾Ï¼¼Æ÷ÀÇ Áõ½ÄÀ» ¾ïÁ¦ÇÑ´Ù´Â °ÍÀ» óÀ½À¸·Î ¹àÇô³Â´Ù. ºÎÀξÏÀÇ ¿¹Èĸ¦ ¿¹ÃøÇÏ´Â ÀÎÀÚ·Î ÀÓ»óÀÎÀÚ¿Í DKK3 ¸Þƿȭ Á¤µµ¸¦ ÇÔ²² °áÇÕÇÏ¸é ¿¹Ãøµµ¸¦ ¸¹ÀÌ ³ôÀÏ ¼ö ÀÖ´Ù´Â »ç½ÇÀ» ¹ßÇ¥Çß¾ú°í, ÇöÀç´Â ¼¼Æ÷ ¹ÛÀ¸·Î ºÐºñµÈ DKK3°¡ ³­¼Ò¾ÏÀÇ Ç×¾ÏÁ¦ ÀúÇ×¼ºÀ» ±Øº¹ÇÒ ¼ö ÀÖÀ½À» ¾Ë¾Æ³»°í ±× ±âÀü ¿¬±¸ ¹× DKK3 Ä¡·áÁ¦¸¦ ¸¸µé°í ÀÖ´Ù. ÀÌÀºÁÖ ±³¼öÀÇ 10³â°£ ³­¼Ò¾Ï ¼ö¼úÇÑ È¯ÀÚµéÀÇ µ¥ÀÌÅ͸¦ ºÐ¼®ÇØ º¸¸é Àå¾×¼º ³­¼Ò¾Ï (¿¹Èİ¡ °¡Àå ¾ÈÁÁÀº ŸÀÔ) 3±â ¸» (stage IIIc) 5³â »ýÁ¸À²ÀÌ 83.7%·Î, Æò±Õ ³­¼Ò¾Ï 3±â¸» 5³â »ýÁ¸À² 23%¿¡ ºñÇØ ¿ùµîÈ÷ ¶Ù¾î³­ Ä¡·á ¼º°ú¸¦ º¸À̰í ÀÖÀ¸¸ç, ±¹°¡¾Ïµî·Ï»ç¾÷ ¿¬·Êº¸°í¼­¿¡ µû¸¥ ¿ì¸®³ª¶ó ¸ðµç º´±â, ¸ðµç ŸÀÔÀÇ ³­¼Ò¾Ï ȯÀÚÀÇ 5³â »ýÁ¸À²Àº 64.1%º¸´Ù ³ôÀº Ä¡·á »ýÁ¸À²À» º¸À̰í ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • Àü³²´ë ÀÇ´ë Çлç
  • Àü³²´ë ÀÇ´ë ¼®»ç
  • Àü³²´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • »ï¼º¼­¿ïº´¿ø »êºÎÀΰú ÀüÀÓÀÇ
  • ¼º±Õ°ü´ëÇб³ ¿¬±¸±³¼ö
  • ¹Ì±¹ M.D. Anderson ¾Ï¼¾ÅÍ ¿¬¼ö
  • ¹Ì±¹ Sidney Kimmel ¾Ï¼¾ÅÍ ¿¬¼ö
  • »ï¼º¼­¿ïº´¿ø »êºÎÀΰú ºÎÀÎÁ¾¾ç ÀÓ»ó°­»ç
  • Áß¾Ó´ëÇб³º´¿ø »êºÎÀΰú ±³¼ö
  • ·Îº¿¼ö¼ú ÀÇ·áÁø

¼ö»ó³»¿ª

Awards List
  • Invited speaker, in The 7th World Congress on Breast Cancer, Cancer Research & Therapy, Las Vegas, NV, USA (2022)
  • Best Award for Fusion Research Project, Chung-Ang University (2019)
  • Invited speaker, in The 4th Symposium of Ease Asian Gene Therapy Innovative Group in Okayama, Japan (2015)
  • Invited speaker, in The 3rd Symposium of Ease Asian Gene Therapy Innovative Group in Suzhou, China (2014)
  • Invited speaker, in The 2nd Symposium of Ease Asian Gene Therapy Innovative Group/The 17th Meeting of the Japan Gene Therapy Interest Group (2013)
  • Best paper award from Korean Society of Assisted Reproduction (2013)
  • Best paper award from Korean Society of Assisted Reproduction (2011)
  • IS Award, The 62nd Annual Congress of the Japan Society of Obstetrics and Gynecology (2010)
  • Best paper award from Korean Society of Gynecologic Oncology and Colposcopy (2003)
  • Avon-AACR International Scholar-in-Training Award (2003)
  • Best paper award from Korean Society of Gynecologic Oncology and Colposcopy (2002)

ÇÐȸȰµ¿

Academic activities
  • 2022 ~ ÇöÀç´ëÇѺÎÀÎÁ¾¾çÇÐȸ È«º¸À§¿øÈ¸ ºÎÀ§¿øÀå
  • 2021 ~ ÇöÀç¿À°¡³ëÀ̵å ÀÇÇבּ¸¼¾Àå
  • 2019 ~ ÇöÀçÇѱ¹¸¶ÀÌÅ©·ÎÁß·ÂÇÐȸ ÇмúÀ§¿ø
  • 2019 ~ ÇöÀç´ëÇѼö¼ú°¨¿°ÇÐȸ ÇмúÀ§¿ø
  • 2019 ~ ÇöÀç´ëÇÑ»êºÎÀΰúÇÐȸ ½É»çÀ§¿øÈ¸
  • 2018 ~ ÇöÀç½ÄǰÀǾàǰ¾ÈÀüó ±¹¹Îû¿ø ¾ÈÀü°Ë»ç ½ÉÀÇÀ§¿ø
  • 2018 ~ ÇöÀçObstetrics & Gynecology Science. Associate Editor
  • 2017 ~ ÇöÀç½ÄǰÀǾàǰ¾ÈÀüó ÀÇ·á±â±âÀ§¿øÈ¸ Àü¹®À§¿ø
  • 2021 ~ 2022´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ ³­¼Ò¾Ï¼ö¼úºÐ°ú À§¿øÀå
  • 2020 ~ 2022´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇмúÀ§¿ø
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Customized small-sized clinostat using 3D printing and novel polydimethylsiloxane culture dish
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö Microgravity
Á¦ ¸ñ Surgical site infection after cytoreductive surgery in patients with ovarian, fallopian tube, and primary peritoneal cancer, is an independent predictor of poor overall survival via significant delays in adjuvant chemotherapy
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö Eur J Gynecol Oncol
Á¦ ¸ñ High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö J Ovarian Res
Á¦ ¸ñ Lumbrokinase, a fibrinolytic enzyme, prevents intra-abdominal adhesion by inhibiting the migrative and adhesive activities of fibroblast via attenuation of the AP-1/ICAM-1 signaling pathway
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö Biomed Research International
Á¦ ¸ñ Robotic-assisted removal of metastatic bulky pelvic lymph nodes followed by concurrent chemoradiation in a patient with FIGO stage IIIC2R cervical adenocarcinoma
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö Int J Gynecol Cancer
Á¦ ¸ñ Clinical Outcomes Associated with Surgical Site Infection in Epithelial Ovarian Fallopian, and Peritoneal Cancer Patients Undergoing Cytoreductive Surgery
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö J Surg Infect
Á¦ ¸ñ Overcoming the limitations of single-site robotic myomectomy via the gradual turning out method without an accessory port, and a know-how
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö Gyne Robot Surg

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

Áß¾Ó´ëÇб³º´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1800-1114
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

Áß¾Ó´ëÇб³º´¿øÀº 727º´»ó°ú 36°³ Áø·á°ú¿Í ¾Ï¼¾ÅÍ, ³úÇ÷°ü¼¾ÅÍ, ½ÉÀåÇ÷°ü¡¤ºÎÁ¤¸Æ¼¾ÅÍ, °©»ó¼±¼¾ÅÍ, ¼ÒÈ­±â¼¾ÅÍ, ôÃß¼¾ÅÍ, È£Èí±â¾Ë·¹¸£±â¼¾ÅÍ µîÀÇ Æ¯¼ºÈ­¼¾ÅÍ·Î ±¸¼ºµÇ¾î 250¿©¸íÀÇ ÀÇ·áÁøÀ» Æ÷ÇÔ °£È£»ç, ÀÇ·á±â»ç µî 2,000¿©¸íÀÇ ±³Á÷¿øÀÌ ÃÖ»óÀÇ ÀÇ·á¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ´Â ÁßÁõÁúȯ Áß½ÉÀÇ ÀÇ·áÇàÀ§¸¦ Àü¹®À¸·Î ÇÏ´Â ¡®»ó±ÞÁ¾ÇÕº´¿ø¡¯ÀÌ´Ù. º´¿øÀº ¾Ï Ä¡·á¿¡ ¸ÂÃãÇü ÀÎÇÁ¶ó¸¦ ±¸ÃàÇØ ¿ø½ºÅé ¼­ºñ½º¿Í ´ÙÇÐÁ¦ Áø·á¸¦ ÅëÇÑ ÃÖÀûÀÇ ¾Ï Ä¡·á °èȹÀ¸·Î ±â´Ù¸®Áö ¾Ê°í ½Å¼ÓÇÑ ¼ö¼ú ¹× Ç¥Àû Ç׾ϡ¤¹æ»ç¼±Ä¡·á¸¦ ½ÃÇàÇÏ´Â ¾Ï¼¾ÅÍ¿Í ½º¸¶Æ®Æù ±â¹Ý µðÁöÅоϼ¾Å͸¦ µ¿½Ã ¿î¿µÇϸç 24½Ã°£ ¿Â¡¤¿ÀÇÁ ±â¹Ý ¾Ï ȯÀÚ Äɾî¿Í ½É°æ¡¤½É¸® ½ºÆ®·¹½º Ä¡·á½Ã½ºÅÛ±îÁö Á¦°øÇϸç ȯÀÚÀÇ »ýÁ¸À²°ú »îÀÇ Áú Çâ»ó ½Ã۰í ÀÖ´Ù. ¶ÇÇÑ, 24½Ã°£ ÀÀ±Þü°è ¹× ÀΰøÁö´É(AI) ¿µ»óÃÔ¿µ ÆÇµ¶½Ã½ºÅÛÀ» ÅëÇÑ ½Å¼ÓÇϰí Á¤¹ÐÇÑ Áø´ÜÀ¸·Î ¸ÂÃãÇü ½Ã¼ú°ú ¼ö¼ú Ä¡·á°¡ ¸ðµÎ °¡´ÉÇÑ ÇÏÀ̺긮µå Ä¡·á ü°è¸¦ °®Ãá ½ÉÀåÇ÷°ü․ºÎÁ¤¸Æ¼¾ÅÍ¿Í ³úÇ÷°ü¼¾ÅÍ¿¡¼­ ÃÖÀûÀÇ Ä¡·á ¼º°ú¸¦ °ÅµÎ°í ÀÖ´Ù. ±×¸®°í, ½Å°æ¿Ü°ú, Á¤Çü¿Ü°ú Àü¹®Àǰ¡ ÅëÁõŬ¸®´Ð°ú ÀçȰÀÇÇаú¿Í À¯±âÀû °øÁ¶Çϴ ôÃß¼¾ÅÍ´Â 'µ¿Àû Áø·á½Ã½ºÅÛ'À¸·Î ÃÖ»óÀÇ È¯ÀÚ È¸º¹À» µ½´Â´Ù. ÇÑÆí, º´¿øÀº °ÔÀÓ °ú¸ôÀÔÀ¸·Î ÀÏ»ó»ýȰ¿¡ ¿µÇâÀ» ¹Þ´Â À̵éÀÇ Á¤È®ÇÑ ¿øÀÎÀ» Áø´ÜÇϰí Ä¡·áÇϱâ À§ÇØ ±¹³» ÃÖÃÊ·Î ¡®°ÔÀÓ °ú¸ôÀÔ Èú¸µ¼¾ÅÍ¡¯¸¦ ¿ÀÇÂÇØ °¡»óÇö½ÇÄ¡·á¿Í Àü¹® »ó´ã ¹× Ä¡·á ÇÁ·Î±×·¥À» ¿î¿µÇϰí Ä¡·áºñ Áö¿ø µî °ÔÀÓ °ú¸ôÀÔ ¹®Á¦¿¡ ´ëÇÑ ½ÇÁúÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇϰí ÀÖ´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀ¸·Î º´¿øÀº ½ÉÆò¿ø ´ëÀå¾Ï, À§¾Ï, À¯¹æ¾Ï, Æó¾Ï µî ¾ÏÄ¡·á ÀûÁ¤¼º Æò°¡ 1µî±Þ, ±Þ¼º±â³úÁ¹Áß, °ü»óµ¿¸Æ¿ìȸ¼ú, ±Þ¼º½É±Ù°æ»öÁõ, Æó·Å µî ±Þ¼º±âÁúȯ Æò°¡ 1µî±Þ, ÀÀ±ÞÀÇ·á¼¾ÅÍ, ¼ºÀΡ¤½Å»ý¾ÆÁßȯÀÚ½Ç Æò°¡ 1µî±Þ µî Àü ºÐ¾ß¿¡ °ÉÃÄ ÃÖ¿ì¼ö µî±Þ Æò°¡¸¦ ¹Þ¾Æ ±¹³» ÃÖ»óÀ§ ÀÇ·á±â°üÀ¸·Î ±× ¿ì¼ö¼ºÀ» ÀÎÁ¤¹Þ°í ÀÖ´Ù. ƯÈ÷, º¸°Çº¹ÁöºÎ¿Í ½ÉÆò¿ø¿¡¼­ óÀ½À¸·Î ½Ç½ÃÇÑ ¡®ÀÇ·á¼­ºñ½º ȯÀÚ°æÇèÆò°¡¡¯¿¡¼­ ´ëÇѹα¹ Àüü Á¾ÇÕ 1À§ÀÇ À§¾÷À» ´Þ¼ºÇØ ¿ì¸®³ª¶ó º´¿ø Áß È¯Àڵ鿡°Ô °¡Àå Ä£ÀýÇÑ º´¿øÀ¸·Î Æò°¡¹Þ°í ÀÖ´Ù.

Áß¾Ó´ëÇб³º´¿ø		 À̹ÌÁö

¼­¿ïƯº°½Ã µ¿ÀÛ±¸ Èæ¼®·Î 102

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä